CURE Pharma Harnesses Cannabinoids to Fight Cancer

In early studies, researchers have found that cannabinoids and terpenes could have strong anti-tumor effects at certain doses, which makes them a compelling target for a U.S. market that’s expected to reach $23 billion by 2020, according to ArcView Research.

Cannabis Stocks Grow 236.1% in 2016!!

New Frontier Data and Viridian Capital Advisors have released a new report that shows marijuana stocks are going up! 

The report looks at the growth in cannabis investing over the past two years, including how the investment community has responded to the 2016 general elections. Cannabis stocks have seen significant growth in recent years, with the Viridian Cannabis Stock Index growing 236.1% in 2016 alone.

High Times Sold to Industry Investor Group

High Times magazine, America’s pioneering cannabis publication, has been sold to a consortium of cannabis industry investors led by the Los Angeles-based investment fund Oreva Capital. The new owners include Damian Marley and Denver Relief's Ean Seeb.

 

A Look Into The Future Of Marijuana Stocks

Forgot the corrections and the politics. It’s all noise compared to simplest, most profitable, and absolutely inevitable trend which will drive marijuana growth for years.